These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3962767)

  • 1. Isolation and characterization of lipocortin (lipomodulin).
    Hirata F; Notsu Y; Yamada R; Ishihara Y; Wano Y; Kunos I; Kunos G
    Agents Actions; 1986 Jan; 17(3-4):263-6. PubMed ID: 3962767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipomodulin: a possible mediator of the action of glucocorticoids.
    Hirata F
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():73-8. PubMed ID: 6221579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The regulation of lipomodulin, a phospholipase inhibitory protein, in rabbit neutrophils by phosphorylation.
    Hirata F
    J Biol Chem; 1981 Aug; 256(15):7730-3. PubMed ID: 6267023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipocortin and vasocortin: two species of anti-inflammatory proteins mimicking the effects of glucocorticoids.
    Sautebin L; Carnuccio R; Ialenti A; Di Rosa M
    Pharmacol Res; 1992 Jan; 25(1):1-12. PubMed ID: 1371190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of a 32-kDa phospholipase A2 inhibitory protein (lipocortin) from human peripheral blood mononuclear cells.
    Rothhut B; Comera C; Prieur B; Errasfa M; Minassian G; Russo-Marie F
    FEBS Lett; 1987 Jul; 219(1):169-75. PubMed ID: 2954855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of lipomodulin, a phospholipase inhibitory protein, in immunoregulation by thymocytes.
    Hirata F; Iwata M
    J Immunol; 1983 Apr; 130(4):1930-6. PubMed ID: 6220071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of eicosanoid and PAF formation by dexamethasone in rat inflammatory polymorphonuclear neutrophils may implicate lipocortin 's'.
    Fradin A; Rothhut B; Poincelot-Canton B; Errasfa M; Russo-Marie F
    Biochim Biophys Acta; 1988 Nov; 963(2):248-57. PubMed ID: 2848583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipocortin--a Ca2+-binding protein which has anti-phospholipase A2 activity].
    Tokuda M; Waisman DM; Hatase O
    Seikagaku; 1988 Jan; 60(1):26-31. PubMed ID: 2969024
    [No Abstract]   [Full Text] [Related]  

  • 9. A purified lipocortin shares the anti-inflammatory effect of glucocorticosteroids in vivo in mice.
    Errasfa M; Russo-Marie F
    Br J Pharmacol; 1989 Aug; 97(4):1051-8. PubMed ID: 2529014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of a human, endogenous, phospholipase A2 inhibitory, antiinflammatory protein.
    Longenecker JP; Rose JW; Giffin K; Shepard D; Johnson LK
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():581-6. PubMed ID: 2959117
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of human natural killer (NK) activity and antibody dependent cellular cytotoxicity (ADCC) by lipomodulin, a phospholipase inhibitory protein.
    Hattori T; Hirata F; Hoffman T; Hizuta A; Herberman RB
    J Immunol; 1983 Aug; 131(2):662-5. PubMed ID: 6223089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity.
    Wallner BP; Mattaliano RJ; Hession C; Cate RL; Tizard R; Sinclair LK; Foeller C; Chow EP; Browing JL; Ramachandran KL
    Nature; 1986 Mar 6-12; 320(6057):77-81. PubMed ID: 2936963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of autoantibody for phospholipase inhibitory protein, lipomodulin, in patients with rheumatic diseases.
    Hirata F; del Carmine R; Nelson CA; Axelrod J; Schiffmann E; Warabi A; De Blas AL; Nirenberg M; Manganiello V; Vaughan M; Kumagai S; Green I; Decker JL; Steinberg AD
    Proc Natl Acad Sci U S A; 1981 May; 78(5):3190-4. PubMed ID: 6114491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biology of phospholipase inhibitory proteins.
    Hirata F; Hirata A
    Adv Exp Med Biol; 1990; 279():211-8. PubMed ID: 2151416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies specific to a Ca2(+)-bound form of lipocortin I distinguish its Ca2(+)-dependent phospholipid-binding ability from its ability to inhibit phospholipase A2.
    Hayashi H; Owada MK; Sonobe S; Domae K; Yamanouchi T; Kakunaga T; Kitajima Y; Yaoita H
    Biochem J; 1990 Aug; 269(3):709-15. PubMed ID: 2143895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoids and head injury. A possible participation of lipocortin (lipomodulin) in actions of the steroid hormones.
    Hirata F
    Neurochem Pathol; 1987 Aug; 7(1):33-45. PubMed ID: 2965797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of leukocyte chemotaxis by Glu-Glu-Glu-Glu-Tyr-Pro-Met-Glu and Leu-Ile-Glu-Asp-Asn-Glu-Tyr-Thr-Ala-Arg-Gln-Gly.
    Hirata F; Notsu Y; Matsuda K; Vasanthakumar G; Schiffmann E; Wong TW; Goldberg AR
    Biochem Biophys Res Commun; 1984 Jan; 118(2):682-90. PubMed ID: 6704100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence and regulation of leukotaxis.
    Schiffmann E; Geetha V; Pencev D; Warabi H; Mato J; Hirata F; Brownstein M; Manjunath R; Mukherjee A; Liotta L; Terranova VP
    Agents Actions Suppl; 1983; 12():106-20. PubMed ID: 6573114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids.
    Hirata F; Schiffmann E; Venkatasubramanian K; Salomon D; Axelrod J
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2533-6. PubMed ID: 6930649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipase A2 and lipocortins, antiphospholipase proteins.
    Di Rosa M; Sautebin L; Carnuccio R
    Methods Enzymol; 1988; 163():23-31. PubMed ID: 2976871
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.